n-3 PUFA: bioavailability and modulation of adipose tissue function.

Area of Science:

• Metabolic Syndrome Research
• Nutritional Biochemistry
• Adipose Tissue Biology

Background:

• Metabolic syndrome (MS) involves obesity, type 2 diabetes, dyslipidaemia, and hypertension, driven by systemic insulin resistance.
• Impaired adipose tissue metabolism and inflammation contribute to MS development.
• n-3 long-chain polyunsaturated fatty acids (LC PUFA) from fish oil show therapeutic potential.

Purpose of the Study:

• To investigate the role of n-3 LC PUFA in preventing MS development.
• To elucidate the mechanisms by which n-3 LC PUFA improve adipose tissue function and insulin sensitivity.
• To highlight n-3 LC PUFA as beneficial dietary components for MS patients.

Main Methods:

• Rodent models were used to study the effects of n-3 LC PUFA on obesity and glucose tolerance.
• Mechanisms of action were investigated, including transcriptional regulation via AMP-activated protein kinase.
• Changes in lipid metabolism, gene expression, and adipose tissue characteristics were analyzed.

Main Results:

• n-3 LC PUFA were shown to prevent obesity and improve glucose tolerance in rodents.
• They activate a metabolic switch promoting lipid catabolism and suppressing lipogenesis in key metabolic tissues.
• Specific effects on adipose tissue include preventing hyperplasia/hypertrophy, inducing mitochondrial biogenesis, increasing adiponectin, and reducing inflammation.

Conclusions:

• n-3 LC PUFA are effective in ameliorating metabolic dysfunction associated with metabolic syndrome.
• Adipose tissue plays a crucial role in mediating the beneficial effects of n-3 LC PUFA.
• Dietary n-3 LC PUFA represent a promising strategy for managing and preventing metabolic syndrome.